Navigation Links
Diabetes II May Be Controlled By Sanofi's New Obesity Pill

Sanofi-Aventis' Accomplia (rimonabant), a new drug for treatment of obesity, has been found to control blood sugar and reduce risk of cardiac problems// in people with diabetes type 2. The research was done on 1,047 overweight or obese patients with type 2 diabetes in Europe and south and North America.

Some of them were given 5 or 20 mg/day of rimonabant, while the others were treated with a placebo, for a 1 year period. Those on the drug showed a vast improvement in terms of weight loss, abdominal fat and waist size reduction and controlled blood sugar levels, and better appetite.

Professor Andre Scheen of the University of Liege in Belgium said that these findings support the usage of 20 mg of the drug daily, along with diet and exercise for treating the disease. The findings have been published online by the Lancet Medical Journal.

These effects of Accomplia reduce the risk of heart disease , stroke, renal damage, blindness and neuropathy which can lead to amputation of the foot. About 194 million people worldwide have diabetes mostly of the type 2 variety . This type is caused by an inability to regulate the glucose in the body properly, and is linked to being overweight or obese.

The standard drugs used are effective in controlling blood sugar levels but lead to weight gain, which makes the illness difficult to treat. Accomplia with its cardiovascular and metabolic effect could prove to be very useful , felt Scheen. It is generally well tolerated , the side effects being nausea, vomiting and anxiety.

The drug has a potential sales of over $3 billion worldwide and Sanofi considers it as its most promising new drug. It is being marketed in Britain, Denmark, Germany, Norway, Ireland, Finland and Austria.
MAL
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Obstetrics Partnering 2010-2016: Deal ... to their offering. --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ... "Global Obstetrics Partnering 2010-2016: Deal trends, ... their offering. --> Research and ...
(Date:2/4/2016)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, announced today that it has ... Morgan Stanley & Co. LLC to repurchase $325 million ... the Company,s previously authorized program to repurchase up to ... --> --> Under the ...
Breaking Medicine Technology: